Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota compositionOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how the duration of high-risk HPV infection and cervical lesion grade relate to the cervical microbiome. Cervical scraping samples were sorted into five groups by infection persistence and pathology. Bacteria were profiled by 16S rRNA sequencing, then KEGG pathway enrichment analysis linked microbes to predicted functions. A random forest machine-learning model with 10-fold cross-validation searched operational taxonomic unit data for biomarkers that could indicate cervical cancer.
Who was studied?
Samples came from 122 women enrolled at Beijing Chao-Yang Hospital in China. This included 91 with high-risk HPV infection (48 persistent, 43 transient) and 31 HPV-negative controls. HPV subtypes included HPV16, HPV18, HPV52, HPV56, and HPV58. Persistent infection meant the same subtype over more than 12 months; transient meant regression within one year. Groups combined persistence status with lesion grade, spanning higher-grade and lower-grade squamous intraepithelial lesions and non-infected cervices.
What were the most important findings?
Compared with HPV-negative cervices, infected samples lost probiotic genera and gained pathogenic bacteria. Lactobacillus, which dominated healthy cervices, fell markedly after infection (LDA score near log 7.3). The largest microbiome shift appeared between transient-infection lesions and non-infected cervices. Certain pathogens increased steadily as infection duration and lesion grade rose, marking possible drivers of progression. HPV infection suppressed pathways including sporulation, porphyrin metabolism, and arginine and proline metabolism. Two markers, OTU851726 and OTU715913, were the strongest candidate indicators of cervical cancer.
What are the greatest implications of this study?
The findings suggest the cervical microbiome shifts in a staged way as HPV infection persists and lesions advance, offering possible markers for risk and progression. Loss of Lactobacillus and rising pathogens fit the idea that microbial imbalance accompanies cervical carcinogenesis. The proposed OTU markers and pathways could guide screening and drug research. The study was observational and cannot prove that microbiome changes cause cancer. Findings depend on detection method and need validation in larger, independent cohorts.